These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 10519387

  • 1. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L.
    Cancer Res; 1999 Oct 01; 59(19):4798-803. PubMed ID: 10519387
    [Abstract] [Full Text] [Related]

  • 2. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S.
    Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.
    Tomizawa Y, Nakajima T, Kohno T, Saito R, Yamaguchi N, Yokota J.
    Cancer Res; 1998 Dec 01; 58(23):5478-83. PubMed ID: 9850082
    [Abstract] [Full Text] [Related]

  • 4. Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients.
    Pylkkanen L, Wolff H, Stjernvall T, Tuominen P, Sioris T, Karjalainen A, Anttila S, Husgafvel-Pursiainen K.
    Int J Oncol; 2002 Feb 01; 20(2):285-90. PubMed ID: 11788890
    [Abstract] [Full Text] [Related]

  • 5. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L, Khan MA, Freedman AN, Gemma A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC.
    Cancer Res; 1998 Jun 15; 58(12):2533-6. PubMed ID: 9635574
    [Abstract] [Full Text] [Related]

  • 6. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 7. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
    Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH.
    Carcinogenesis; 2004 Nov 01; 25(11):2165-71. PubMed ID: 15231689
    [Abstract] [Full Text] [Related]

  • 8. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Field JK, Kittas C.
    J Pathol; 2001 Jan 01; 193(1):55-65. PubMed ID: 11169516
    [Abstract] [Full Text] [Related]

  • 9. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J, Cheng YW, Wu DW, Chen JT, Chen CY, Chou MC, Lee H.
    Cancer Lett; 2006 Apr 08; 235(1):18-25. PubMed ID: 15935551
    [Abstract] [Full Text] [Related]

  • 10. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT.
    Cancer Res; 1998 May 01; 58(9):1804-7. PubMed ID: 9581816
    [Abstract] [Full Text] [Related]

  • 11. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
    Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese ML, Goldstraw P, Huebner K, Croce CM, Pierotti MA.
    Cancer Res; 1997 Dec 01; 57(23):5207-12. PubMed ID: 9393735
    [Abstract] [Full Text] [Related]

  • 12. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD.
    Cancer Res; 2000 Apr 01; 60(7):1949-60. PubMed ID: 10766185
    [Abstract] [Full Text] [Related]

  • 13. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A, Srinivasan R, Shabnam MS, Majumdar S, Joshi K, Behera D.
    Mol Cancer Res; 2006 Feb 01; 4(2):93-9. PubMed ID: 16513840
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 01; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 15. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M.
    Int J Oncol; 2005 Aug 01; 27(2):481-8. PubMed ID: 16010431
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular genetics of small cell lung carcinoma.
    Wistuba II, Gazdar AF, Minna JD.
    Semin Oncol; 2001 Apr 01; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [Abstract] [Full Text] [Related]

  • 19. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
    Wistuba II, Ashfaq R, Maitra A, Alvarez H, Riquelme E, Gazdar AF.
    Am J Pathol; 2002 Jun 01; 160(6):2073-9. PubMed ID: 12057912
    [Abstract] [Full Text] [Related]

  • 20. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD.
    Cancer Res; 2001 May 01; 61(9):3581-5. PubMed ID: 11325823
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.